Aura Biosciences (AURA) Operating Leases (2021 - 2026)
Aura Biosciences (AURA) posted Operating Leases of $13.3 million for Q2 2026, down 10.8% from $14.92 million a year earlier and down 3.1% from the prior quarter.
Powered by 
Analysis
Aura Biosciences (AURA) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025, Aura Biosciences' Operating Leases came in at $14.13 million, down 9.5% from FY2024.
- Annual Operating Leases has declined for three consecutive years, though with a four-year compound annual growth rate of 150.3% (FY2021 to FY2025).
- In prior years, Aura Biosciences' Operating Leases was $15.62 million in FY2024 (-7.4%), $16.87 million in FY2023 (-5.7%), $17.9 million in FY2022 and $360,000 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Operating Leases since Q2 2022.
- On a year-over-year basis, Operating Leases has declined in each of the last 12 quarters, with an average decline of 8.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 5.4% (Q3 2023) to 10.8% (Q2 2026).
- According to Business Quant data, Operating Leases for the three prior quarters was $13.72 million (Q1 2026), $14.13 million (Q4 2025) and $14.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Aura Biosciences | 796.17 Mn | 542.36 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.85 Mn |
| Jun 30, 2026 | 13.30 Mn |
| Mar 31, 2026 | 13.72 Mn |
| Dec 31, 2025 | 14.13 Mn |
| Sep 30, 2025 | 14.53 Mn |
| Jun 30, 2025 | 14.92 Mn |
| Mar 31, 2025 | 15.27 Mn |
| Dec 31, 2024 | 15.62 Mn |
| Sep 30, 2024 | 15.96 Mn |
| Jun 30, 2024 | 16.28 Mn |
| Mar 31, 2024 | 16.58 Mn |
| Dec 31, 2023 | 16.87 Mn |
| Sep 30, 2023 | 17.15 Mn |
| Jun 30, 2023 | 17.41 Mn |
| Mar 31, 2023 | 17.65 Mn |
| Dec 31, 2022 | 17.90 Mn |
| Sep 30, 2022 | 18.13 Mn |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 206,000.00 |
| Dec 31, 2021 | 360,000.00 |
API Access
Aura Biosciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=AURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "AURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=AURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();